MMMasakazu Mimaki

Masakazu Mimaki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Masakazu Mimaki has a total of 41 co-authors. Here are the top co-authors by number of shared publications:

  • Shinya Tomori

    Department of Pediatrics Teikyo University School of Medicine Tokyo Japan

    2 shared publications
  • Ayuka Murakami

    Department of Neurology, Nagoya University Graduate School of Medicine, Aichi, Japan

    1 shared publication
  • Brian Hon-Yin Chung

    Department of Pediatrics and Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China

    1 shared publication
  • Christopher Chun-Yun Mak

    Department of Pediatrics and Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China

    1 shared publication
  • Hideki Hoshino

    Department of Pediatrics Teikyo University School of Medicine Itabashi‐ku Tokyo Japan

    1 shared publication
  • Ichizo Nishino

    Department of Neuromuscular Research National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP) Tokyo Japan

    1 shared publication

Latest Publications

  • Limited Clinical Associations of Age‐Adjusted Serum Thymus and Activation‐Regulated Chemokine in Kawasaki Disease

    by Shinya Tomori, Kazuhiro Takahashi, Takayuki Koyama, Masakazu Mimaki

    Background: Kawasaki disease is an acute systemic vasculitis, and the clinical significance of serum thymus and activation‐regulated chemokine (TARC) remains incompletely understood. We examined whether pre‐treatment age‐adjusted serum TARC was associated with inflammation‐based intravenous immunoglobulin (IVIG) resistance risk stratification. Methods: We retrospectively studied 109 children with Kawasaki disease after excluding documented allergic comorbidities and age younger than 6 months. All included patients had serum TARC measured before initial treatment, and 18 of them also had paired post‐treatment measurements. Serum values were expressed as the percentage of the age‐specific upper limit of normal. The primary analysis compared pre‐treatment values between high‐ and low‐risk groups according to the Kobayashi score. Paired pre‐ and post‐treatment changes and exploratory analyses of other IVIG resistance risk scores and treatment non‐response were also assessed. Results: Twenty children were classified as high risk by the Kobayashi score. Pre‐treatment age‐adjusted values were lower in the high‐risk group than in the low‐risk group, but logistic regression analysis did not support a statistically robust association. In 18 children with paired samples, values decreased significantly after treatment. Exploratory analyses showed no significant associations with other IVIG resistance risk scores, whereas analyses of treatment non‐response and coronary artery lesions were limited by the small number of events. Conclusions: Age‐adjusted serum TARC showed limited clinical associations during the acute phase of Kawasaki disease and was not robustly associated with inflammation‐based high‐risk classification. Its role in treatment response and coronary artery outcomes remains to be clarified.

  • Association between QTA30 scores and headache‐related assessments in children

    by Toshiyuki Hikita, Hideki Hoshino, Masakazu Mimaki

    Background: The QTA30 is a simple questionnaire used to assess physical and mental health in children. Headache‐related disability and impact are commonly evaluated using the Pediatric Migraine Disability Assessment (PedMIDAS) and the Headache Impact Test‐6 (HIT‐6). This study examined the relationship between physical and mental health assessed by the QTA30 and headache‐related assessments in pediatric patients. Method: This study included patients who visited Hikita Pediatric Clinic from April 2023 to March 2025 and completed the QTA30, PedMIDAS, and HIT‐6. Associations between assessment scores were analyzed using Spearman's rank correlation coefficient. Results: A total of 68 patients were included, with a median age of 13 years (range: 6–17); 43 were female. The median total QTA30 score was 37 (range: 4–78), the median PedMIDAS score was 15.5 days (range: 0–148), and the median HIT‐6 score was 62.5 (range: 26–78). The total QTA30 score showed a moderate positive correlation with PedMIDAS ( r = 0.4, p = 0.0007). In contrast, no significant correlation was observed between the total QTA30 score and HIT‐6 ( r = 0.11, p = 0.36). The physical symptoms subscale of the QTA30 demonstrated a strong positive correlation with PedMIDAS ( r = 0.51, p < 0.0001), while the anxiety subscale was also positively correlated with PedMIDAS ( r = 0.31, p = 0.0091). Conclusions: Physical and mental health measures assessed by the QTA30 were associated with PedMIDAS, which reflects headache‐related disability and duration, but not with HIT‐6, which primarily reflects headache intensity.

  • Open Access

    A novel m.14677 T > C variant in mitochondrial tRNAGlu gene causes chronic progressive external ophthalmoplegia

    by Nahoko Katayama Ueda, Masakazu Mimaki, Shota Ito, Ayuka Murakami, Satoshi Yokoi, Ichizo Nishino, Masahisa Katsuno, Yu-Ichi Goto

    Chronic progressive external ophthalmoplegia (CPEO) is a mitochondrial disease characterized by progressive ptosis and ophthalmoplegia, caused by single deletions, point mutations, or multiple deletions in mitochondrial DNA (mtDNA). Most point mutations occur in tRNA genes. Here, we report a novel variant of the tRNA Glu gene associated with CPEO. A 45-year-old male presented with ptosis and external ophthalmoplegia; however, blood test results, including lactate levels and autoantibodies, were normal. CPEO was suspended, prompting additional myopathological examination, mtDNA sequencing analysis, long polymerase chain reaction (PCR) analysis, and single-fiber analysis to compare mutation loads between ragged-red fibers (RRFs) and non-RRFs. Histopathological examination revealed scattered COX-negative RRFs. No deletions were found in the mtDNA. MtDNA sequencing analysis revealed a novel variant, m.14677 T > C, in the tRNA Glu gene, with Sanger sequencing indicating 45% heteroplasmy in the muscle tissue. Single-fiber analysis showed a significantly higher mutation load of m.14677 T > C in RRFs (range: 25.3–92.8%; median: 88.1%; n = 6) compared with non-RRFs (range: 3.5–85.9%; median: 17.1%; n = 5) (P = 0.03). Based on the significantly higher mutation load in RRFs than in non-RRFs, pathological evidence of mitochondrial disease, and the mutation’s occurrence at an evolutionarily conserved site, we concluded that m.14677 T > C, a novel variant of the tRNA Glu gene, is the cause of CPEO. Biochemical and histopathological examinations of muscle tissue, combined with single-fiber analysis, are valuable tools for evaluating mtDNA variants, particularly those within tRNA genes.


  • Open Access

    NDUFB7 mutations cause brain neuronal defects, lactic acidosis, and mitochondrial dysfunction in humans and zebrafish

    by Yen-Lin Chen, Brian Hon-Yin Chung, Masakazu Mimaki, Shumpei Uchino, Yin-Hsiu Chien, Christopher Chun-Yun Mak, Steven Shinn-Forng Peng, Wei-Chen Wang, Yu-Li Lin, Wuh-Liang Hwu, et al.

    Complex I of the mitochondrial electron transfer chain is one of the largest membrane protein assemblies ever discovered. A patient carrying a homozygous NDUFB7 intronic mutation died within two months after birth due to cardiorespiratory defects, preventing further study. Here, we report another patient with compound heterozygous mutations in NDUFB7 who suffers from pons abnormality, lactic acidosis, prematurity, prenatal and postnatal growth deficiency, incomplete closure of the abdominal wall (ventral hernia), and a poorly functioning gastrointestinal tract (pseudo-obstruction). We demonstrated that the patient’s skin fibroblasts are deficient in Complex I assembly and reduced supercomplex formation. This report further broadens the spectrum of mitochondrial disorders. The patient has had several surgeries. After receiving treatment with Coenzyme Q10 and vitamin B complex, she has remained stable up to this point. To further explore the functionality of NDUFB7 in vivo, we knocked down Ndufb7 in zebrafish embryos. This resulted in brain ventricle and neuronal defects, elevated lactic acid levels, and reduced oxygen consumption, indicating defective mitochondrial respiration. These phenotypes can be specifically rescued by ectopic expression of ndufb7. More importantly, Mitoquinone mesylate (MitoQ), a common remedy for mitochondrial disorders, can ameliorate these conditions. These results suggest a role for NDUFB7 in mitochondrial activity and the suitability of the zebrafish model for further drug screening and the development of therapeutic strategies for this rare disease.


  • First report of familial hemolytic anemia due to hemoglobin Sabine in Asia

    by Kazuna Yamamoto, Kozue Nakamura, Ryosuke Shiozawa, Satoru Iwashima, Masakazu Mimaki

  • Open Access

    Effects of Temperature and Position Change on Neonatal Brain Regional Oxygen Saturation in Tub Bathing: A Prospective Study

    by Tomohiko Nishino, Naoki Ito, Shinya Tomori, Satoshi Shimada, Misaki Kodera, Kiyoko Morita, Kazuhiro Takahashi, Masakazu Mimaki

    Introduction A major goal in neonatal medicine is to reduce stress as much as possible in routine care. Bathing is one of the important routine cares for neonates, but it makes a big environmental change for them. We aimed to examine whether water temperature, room temperature, and position changes in tub bathing serve as noxious stimuli to neonates. Methods This prospective trial was performed in full-term and non-low-birth-weight neonates admitted to the hospital between July 2020 and March 2021. Those with underlying diseases, fetal distress, infection, and other medical conditions were excluded. Measurements were taken during the neonates’ first tub bath since birth, which was performed by a trained nurse. Changes in regional oxygen saturation (rSO2), determined using near-infrared spectroscopy, and water and room temperature, were examined at five different time points: upon entering the bath, head washing, position change, exiting the bath, and during the 3 min after bathing. Results In total, 17 neonates were analyzed. No changes in rSO2 due to head washing or position change were observed; however, rSO2 significantly decreased upon entering (78.5 ± 4.1% vs. 75.7 ± 4.1%, p < 0.001) and exiting the bath (75.8 ± 5.7% vs. 74.4 ± 5.4%, p < 0.04). The rate change in rSO2 upon entering the bath showed a significant inverse correlation with water temperature (r = − 0.53, p < 0.03), and there were no significant correlations between rSO2 and water or room temperature upon exiting the bath. There was no change in body skin temperature before and after bathing, but rSO2 gradually decreased during the 3 min after bathing. Conclusions Neonates may perceive certain temperatures during bathing as noxious stimuli. Therefore, methods to minimize stress associated with bathing should be implemented to reduce the difference between water temperature and room temperature during bathing. Trial registration This trial has been registered at UMIN repository with the trial number UMIN000041045 (https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046500). The date of the final dataset was April 01, 2021.


  • 3.63 Prevalence and Prediction of Suicide Ideation in Japanese Adolescents: Results From a Population-Based Questionnaire Survey

    by Shinichiro Nagamitsu, Masakazu Mimaki, Kenji Koyanagi, Natsuko Tokita, Yoriko Kobayashi, Ritsuko Hattori, Yushiro Yamashita, Zentaro Yamagata, Takashi Igarashi